iOrganBio is transforming human cell production with CellForge, its AI-powered platform for consistent, scalable, and intelligent manufacturing of cells and organoids for in vitro modeling and cell therapies. By applying engineering precision to biology, CellForge uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles. At the core of the platform is iOrganBio's Functional Human Cell Atlas, a comprehensive reference built from single-cell and multi-omics data that provides the digital blueprints for each cell type. This smart, closed-loop process provides the accuracy, efficiency, and quality partners need to turn scientific ideas into breakthroughs-accelerating disease modeling, regenerative medicine, and drug development. iOrganBio is based at BioLabs in Chapel Hill, NC.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/29/25 | $2,000,000 |
2ndF Alix Ventures Cape Fear BioCapital First Star Venture Capital  IndieBio Terasaki Institute | undisclosed |
